Beam Therapeutics logo

Beam Therapeutics share price today

(BEAM)

Beam Therapeutics share price is $28.7 & ₹2,447.25 as on 27 Dec 2024, 2.30 'hrs' IST

$28.7

-0.11

(-0.38%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Beam Therapeutics share price in Dollar and Rupees. Guide to invest in Beam Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Beam Therapeutics. Get details on the Indian mutual funds that are investing in Beam Therapeutics. Get Analyst recommendations and forecasts along with all the Beam Therapeutics's financials.

Beam Therapeutics share price movements

  • Today's Low: $27.82
    Today's High: $29.11

    Day's Volatility :4.43%

  • 52 Weeks Low: $20.84
    52 Weeks High: $49.50

    52 Weeks Volatility :57.9%

Beam Therapeutics Returns

PeriodBeam Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
14.57%
-8.8%
0.0%
6 Months
22.49%
-4.3%
0.0%
1 Year
-2.48%
2.7%
0.0%
3 Years
-63.44%
-0.8%
-21.8%

Beam Therapeutics Key Statistics

in dollars & INR

Previous Close
$28.81
Open
$28.41
Today's High
$29.11
Today's Low
$27.82
Market Capitalization
$2.4B
Today's Volume
$570.1K
52 Week High
$49.5
52 Week Low
$20.84
Revenue TTM
$349.6M
EBITDA
$-160.8M
Earnings Per Share (EPS)
$-1.58
Profit Margin
-41.07%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-18.29%

How to invest in Beam Therapeutics from India?

It is very easy for Indian residents to invest directly in Beam Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Beam Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Beam Therapeutics or BEAM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Beam Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Beam Therapeutics shares which would translate to 0.030 fractional shares of Beam Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Beam Therapeutics, in just a few clicks!

Returns in Beam Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Beam Therapeutics investment value today

Current value as on today

₹1,00,037

Returns

₹37

(+0.04%)

Returns from Beam Therapeutics Stock

₹2,480 (-2.48%)

Dollar Returns

₹2,518 (+2.52%)

Indian investors sentiment towards Beam Therapeutics

135%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Beam Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 27, 2024. 135% more investors are searching Beam Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Beam Therapeutics

  • Farallon Capital Management, L.L.C.

    9.91%

  • Vanguard Group Inc

    9.47%

  • BlackRock Inc

    9.22%

  • ARK Investment Management LLC

    7.89%

  • ARCH VENTURE CORP

    5.84%

  • FMR Inc

    5.09%

Analyst Recommendation on Beam Therapeutics

Buy

    61%Buy

    38%Hold

    0%Sell

Based on 21 Wall street analysts offering stock ratings for Beam Therapeutics(by analysts ranked 0 to 5 stars)

Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
13
Hold
8
8
8
Sell
0
0
0

Analyst Forecast on Beam Therapeutics

What analysts predicted

Upside of 71.43%

Current:

$28.70

Target:

$49.20

Insights on Beam Therapeutics

  • Price Movement

    In the last 7 days, BEAM stock has moved down by -1.1%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 7.41M → 14.26M (in $), with an average increase of 27.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -91.05M → -96.66M (in $), with an average decrease of 6.2% per quarter
  • BEAM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.4% return, outperforming this stock by 24.7%
  • BEAM vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 50.5% return, outperforming this stock by 114.7%
  • Price to Sales

    ForBEAM every $1 of sales, investors are willing to pay $6.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Beam Therapeutics Technicals Summary

Sell

Neutral

Buy

Beam Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Beam Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Beam Therapeutics Inc
5.51%
22.49%
-2.48%
-63.44%
-63.08%
Regeneron Pharmaceuticals, Inc.
-5.06%
-31.81%
-18.72%
12.25%
91.78%
Biontech Se
-5.76%
41.58%
7.61%
-52.87%
225.9%
Alnylam Pharmaceuticals, Inc.
-4.43%
-0.21%
23.91%
43.75%
111.44%
Vertex Pharmaceuticals Incorporated
-11.6%
-12.39%
0.34%
85.04%
87.54%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Beam Therapeutics Inc
NA
NA
NA
-4.72
-0.18
-0.09
NA
9.97
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.07
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Beam Therapeutics Inc
Buy
$2.4B
-63.08%
NA
-41.07%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.78%
17.67
33.61%
Biontech Se
Buy
$27.4B
225.9%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
111.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
87.54%
32.84
-4.51%

Beam Therapeutics Dividend announcements

  • Beam Therapeutics Earnings

    Beam Therapeutics’s price-to-earnings ratio stands at None

    Read More

About Beam Therapeutics

beam therapeutics is developing precision genetic medicines for serious diseases. co-founded by scientific pioneers known for advancing crispr gene editing, we’re the first company to pursue development of new therapies using crispr base editing technology. we aim to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point mutations, write in protective genetic variations, or modulate the expression or function of disease-causing genes. who we are beam is creating precision genetic medicines through base editing why we do it our dream is to provide life-long cures for patients suffering from serious diseases who we are and how we work together the beam team:  a community of fearless innovators  rigorous and honest in our research  listening with open minds  committed to each other
Organization
Beam Therapeutics
Employees
472
CEO
Mr. John M. Evans M.B.A.
Industry
Health Technology

Management People of Beam Therapeutics

NameTitle
Mr. John M. Evans M.B.A.
CEO & Director
Dr. Giuseppe Ciaramella Ph.D.
President
Dr. Christine P. Bellon J.D., Ph.D.
Senior VP, Chief Legal Officer & Corporate Secretary
Dr. Amy Simon M.D.
Chief Medical Officer
Dr. Feng Zhang Ph.D.
Co-Founder
Dr. David R. Liu Ph.D.
Co-Founder
Dr. J. Keith Joung M.D., Ph.D.
Co-Founder
Dr. Manmohan Singh Ph.D.
Chief Technology Officer
Dr. Gopi Shanker Ph.D.
Chief Scientific Officer
Ms. Susan O'Connor
Chief Human Resources Officer

Important FAQs about investing in Beam Therapeutics from India :

What is Beam Therapeutics share price today?

Beam Therapeutics share price today stands at $28.70, Open: $28.41 ; Previous Close: $28.81 ; High: $29.11 ; Low: $27.82 ; 52 Week High: $49.50 ; 52 Week Low: $20.84. The stock opens at $28.41, after a previous close of $28.81. The stock reached a daily high of $29.11 and a low of $27.82, with a 52-week high of $49.50 and a 52-week low of $20.84.

Can Indians buy Beam Therapeutics shares?

Yes, Indians can invest in the Beam Therapeutics (BEAM) from India.

With INDmoney, you can buy Beam Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Beam Therapeutics at zero transaction cost.

How can I buy Beam Therapeutics shares from India?

It is very easy to buy Beam Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Beam Therapeutics be purchased?

Yes, you can buy fractional shares of Beam Therapeutics with INDmoney app.

What are the documents required to start investing in Beam Therapeutics stocks?

To start investing in Beam Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Beam Therapeutics

Today’s highest price of Beam Therapeutics (BEAM) is $29.11.

Today’s lowest price of Beam Therapeutics (BEAM) is $27.82.

What is today's market capitalisation of Beam Therapeutics

Today's market capitalisation of Beam Therapeutics BEAM is 2.4B

What is the 52 Week High and Low Range of Beam Therapeutics

  • 52 Week High

    $49.50

  • 52 Week Low

    $20.84

What are the historical returns of Beam Therapeutics?

  • 1 Month Returns

    5.51%

  • 3 Months Returns

    22.49%

  • 1 Year Returns

    -2.48%

  • 5 Years Returns

    -63.08%

Who is the Chief Executive Officer (CEO) of Beam Therapeutics

Mr. John M. Evans M.B.A. is the current Chief Executive Officer (CEO) of Beam Therapeutics.